IncF plasmid diversity in multi-drug resistant Escherichia coli strains from animals in China by Qiu-E. Yang et al.
ORIGINAL RESEARCH
published: 22 September 2015
doi: 10.3389/fmicb.2015.00964
Frontiers in Microbiology | www.frontiersin.org 1 September 2015 | Volume 6 | Article 964
Edited by:
Alexandre Gonçalves,
University of Trás-os-Montes e Alto
Douro, Portugal
Reviewed by:
Teresa M. Coque,
Hospital Universitario Ramón y Cajal,
Spain
Lei Dai,
Iowa State University, USA
Maria Jose Gosalbes,
CIBER, Spain
*Correspondence:
Ya-Hong Liu,
Laboratory of Veterinary
Pharmacology, College of Veterinary
Medicine, South China Agricultural
University, 483 Wushan Street,
Tianhe District,
Guangzhou 510642, China
gale@scau.edu.cn
†Present Address:
Bao-Tao Liu,
College of Animal Science and
Technology, Qingdao Agricultural
University, Qingdao, China
‡These authors have contributed
equally to this work.
Specialty section:
This article was submitted to
Antimicrobials, Resistance and
Chemotherapy,
a section of the journal
Frontiers in Microbiology
Received: 18 April 2015
Accepted: 31 August 2015
Published: 22 September 2015
Citation:
Yang Q-E, Sun J, Li L, Deng H, Liu
B-T, Fang L-X, Liao X-P and Liu Y-H
(2015) IncF plasmid diversity in
multi-drug resistant Escherichia coli
strains from animals in China.
Front. Microbiol. 6:964.
doi: 10.3389/fmicb.2015.00964
IncF plasmid diversity in multi-drug
resistant Escherichia coli strains
from animals in China
Qiu-E. Yang1‡, Jian Sun1‡, Liang Li 1, Hui Deng1, Bao-Tao Liu 1†, Liang-Xing Fang1,
Xiao-Ping Liao1 and Ya-Hong Liu 1, 2*
1 Laboratory of Veterinary Pharmacology, College of Veterinary Medicine, South China Agricultural University, Guangzhou,
China, 2 Jiangsu Co-Innovation Centre for Prevention and Control of Important Animal Infectious Diseases and Zoonoses,
Yangzhou, China
The purpose of this study was to characterize a collection of 103 multidrug resistance
IncF plasmids recovered from Escherichia coli of food producing and companion animals
between 2003 and 2012. A total of 103 incF plasmids were characterized using an
established PCR-based IncF replicon sequence typing (RST) system to identify FII, FIA,
and FIB (FAB) groups. Plasmids were also analyzed using-restriction fragment length
polymorphism (RFLP). Antibiotic Resistance determinants blaCTX-M, plasmid-mediated
quinolone resistance (PMQR) genes and rmtB and plasmid addiction systems (PAS) were
identified by PCR screening. A total of 20 different RSTs from 103 IncF plasmids were
identified. The groups F2 and F33 with the RST formulae A-: B- were the most frequently
encountered types (63.1%). The antibiotic resistance genes (ARGs) blaCTX-M, rmtB, and
oqxB were carried by 82, 37, and 34 IncF plasmids, respectively. Most of these plasmids
carried more than one resistance gene (59.2%, 61/103). The IncF plasmids also had
a high frequency of addiction systems (mean 2.54) and two antisense RNA-regulated
systems (hok–sok and srnBC) and a protein antitoxin-regulated system (pemKI) were the
most prevalent. Not surprisingly, RFLP profiles among the IncF plasmids were diverse
even though some shared identical IncF-RSTs. This is the first extensive study of IncF
plasmid-positive E. coli isolates from animals in China. Our results demonstrate that
IncF is the most prevalent plasmid family in E. coli plasmids and they commonly carry
multiple resistance determinants that render them resistant to different antibiotic classes
simultaneously. IncF plasmids also harbor addiction systems, promoting their stability
and maintenance in the bacterial host, under changing environmental conditions.
Keywords: Escherichia coli, IncF plasmid, multi-resistance, addiction systems, RFLP
Introduction
Increasing antibiotic resistance in bacteria has potentially disastrous consequences for human
and animal health around the world. Recent studies have demonstrated that plasmids act
as eﬃcient vehicles for the spread of antibiotic resistance genes (ARGs) more frequently
than previously believed (Taylor et al., 2004; García-Fernández et al., 2009; Dolejska
et al., 2011; Accogli et al., 2013; Carattoli, 2013; Dahmen et al., 2013b). Thus far, 27
diﬀerent plasmid incompatibility (Inc.) groups are recognized in the Enterobacteriaceae
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(Couturier et al., 1988; Carattoli et al., 2005; Villa et al.,
2010). A smaller number of particular plasmid families play a
major role in the diﬀusion of speciﬁc resistance genes among
Enterobacteriaceae and are the most frequently encountered.
The IncF plasmids represent one of the most prevalent
incompatibility types, and have been identiﬁed worldwide in
Enterobacteriaceae from diﬀerent origins and sources (Carattoli,
2009; Mathers et al., 2015). Currently, a total of 924 plasmids
have been deposited at the plasmid multilocus sequence typing
(pMLST) database (http://pubmlst.org/plasmid/, 30 January,
2015). Of these, 214 plasmids belong to IncF group and 158 of
them (73.8%) recovered from Escherichiacoli could be classiﬁed
in 90 diﬀerent subgroups on the basis of their FII, FIA and FIB
(FAB) alleles.
IncF plasmids have systems which guarantee their
autonomous replication but also encode addiction systems
frequently based on toxin-antitoxin factors. These systems
contribute to control their copy number and ensurethe instable
inheritance during cell division (Cohen, 1976; Kado, 1998; Hayes,
2003). In our previous studies, we found that IncF plasmids could
integrate a wide range of genes conferring resistance to all major
classes of antimicrobials including β-lactams, aminoglycosides,
tetracyclines, chloramphenicol, and quinolones (Liao et al.,
2013; Liu et al., 2013). The extended-spectrum β-lactamases
(ESBLs), especially those of the CTX-M type, are often associated
with plasmid-mediated quinolone resistance (PMQR) and
aminoglycoside resistance genes. Plasmids belonging to the IncF
group have been the primary hosts for these traits (Boyd et al.,
2004; Yao et al., 2011; Matsumura et al., 2013; Ogbolu et al.,
2013).
The spread of such multidrug resistance plasmids among
Enterobacteriaceae strains could also aﬀect clinical treatments.
For instance, IncF-blaCTX-M association was observed from both
human and animal E. coli isolates such as the IncF-like plasmid
R100 involved in the dissemination of blaCTX-M-14 in Hong
Kong, United Kingdom and France (Woodford et al., 2009; Ho
et al., 2012; Dahmen et al., 2013a). The genes rmtB, qepA, qnr,
fosA3, and oqxAB have been recently identiﬁed on IncF plasmids
in E. coli from China, Korea and Spain (Tamang et al., 2008; Li
et al., 2012; Ruiz et al., 2012; Ho et al., 2013). All together, the
IncF-related family has the potential to be a major contributor
worldwide to the diﬀusion of diﬀerent resistance genes.
In general, the IncF plasmids are not a homogeneous group
and vary in size (50–200 kb) and replicon type (Garcillán-
Barcia et al., 2009; de Been et al., 2014; Lanza et al., 2014).
Most importantly, plasmids encoding virulence-associated traits
fall almost exclusively within IncF group (Johnson and Nolan,
2009). Therefore, knowledge of the prevalence and IncF plasmid
subtypes in resistant populations could be a useful aid in
exploring novel plasmid-targeting strategiesto treat resistant
bacteria (Osborn et al., 2000; DeNap and Hergenrother, 2005;
Baquero et al., 2011). We investigated variations in IncF plasmids
and the phylogenetic relationship among IncF plasmids from
diﬀerent sources using RST and RFLP analyses. This study
characterized IncF plasmids according to resistance genes,
genetic relatedness and addiction systems in 103 E. coli isolates
from pigs, poultry and companion animals.
Materials and Methods
Transconjugants and Antibiotic Susceptibility
Testing
A total of non-duplicate 795 E. coli were isolated from
animals between 2002 and 2012, according to the data
published in our previous study (Liao et al., 2013; Liu
et al., 2013, 2014). Among them, 696 E. coli were isolated
from liver, heart or faces samples of diseased food-producing
animals including 318 from avian (177 from ducks, 110 from
chicken and 31 from geese) and 378 from pigs. The food-
producing animals originated from more than 80 farms all
over Guangdong province. The remaining 99 isolates were
from rectal swab samples of pets including 71 dogs and 28
cats in ﬁve animal hospitals in Guangdong province. Further
information about these animals, the underlying disease
and possible antimicrobial pretreatment were unfortunately
not available. One suspected colony with typical E. coli
morphology and size was selected from all agar plates of
each sample and was identiﬁed by Matrix Assisted Laser
Desorption/lionization Time-of-Flight mass spectrometry
(MALDI-TOF VITEK MS RUO System) using the Saramis™
database (bioMérieux, France). The genetic relatedness among
partial E. coli isolates randomly selected were determined by
pulsed-ﬁeld gel electrophoresis (PFGE) with XbaI according
to a protocol described previously (Gautom, 1997). Isolates
encoding blaCTX−M, rmtB and/or PMQR gene (535/795), were
selected for conjugation experiments by the broth-mating
method using streptomycin-resistance E. coli C600 as the
recipient. Transconjugants were selected on MacConkey
agar plates containing streptomycin (1000mg/L) and
cefotaxime (2mg/L)/amikacin (32mg/L)/olaquindox (64mg/L),
respectively. The transconjugants harboring blaCTX-M, rmtB,
and/or PMQR gene mentioned above were conﬁrmed by PCR as
previously.
One hundred and three transconjugants, each carrying
one single IncF plasmid, were selected from a collection of
clonally unrelated E. coli strains (15 pets, 43 avian, and 45
pigs) in our study. Table S1 contains detailed information
for this population. Within this group 28 IncF plasmids
had been previously characterized (Liao et al., 2013; Liu
et al., 2013, 2014). Antimicrobial susceptibility tests were
determined by agar dilution method on Mueller-Hinton agar
plates. The antimicrobial drugs studied included quinolones
(nalidixicacid), ﬂuoroquinolones (ciproﬂoxacin, enroﬂoxacin,
and levoﬂoxacin), ampicillin, third-generation cephalosporins
(ceftiofur, cefotaxime and ceftazidime), aminoglycoside
(streptomycin, amikacin, kanamycin, and gentamycin) and
other antimicrobials (olaquindox, chloramphenicol, ﬂorfenicol,
and tetracyclines). The susceptibility tests were carried out
and evaluated according to the guidelines of the Clinical and
Laboratory Standards Institute (CLSI). The breakpoints for
each antimicrobial were those recommended by the CLSI
(M100-S19), CLSI (Vet01-A4/Vet01-S2), and DANMAP 98
(olaquindox) (Clinical and Laboratory Standards Institute,
2008, 2013). E. coli ATCC 25922 was used for quality control
purposes.
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Detection of Antimicrobial Resistance Genes
The total DNA of transconjugants harvested from LB broth were
extracted by TIANPrep Plasmid Mini Kit (TIANGEN Biotech,
Beijing, China), according to the manufacturer’s instructions.
The blaCTX-M, rmtB, and PMQR genes were screened by
PCR using primers as described previously (Cano et al.,
2009; Wang et al., 2012). The blaCTX-M, rmtB, and oqxB-
positive transconjugants were also evaluated for the presence
of other PMQR genes (qnrA, qnrB, qnrC, qnrD, qnrS, and
qepA). PCR products were sequenced and compared with
the reported sequences from GenBank (www.ncbi.nlm.nih.
gov/genbank/).
IncF Plasmid Analysis
Plasmid DNA was extracted by QIAGENPrep Plasmid Midi Kit
(QIAGEN, Hilden, Germany), according to the manufacturer’s
instructions. PCR-base replicon typing (PBRT) was performed
on all transconjugants carrying a single plasmid, as previously
described (Carattoli et al., 2005). To better characterize IncF,
replicon sequencing typing (RST) was performed according to
protocols described previously (Villa et al., 2010), and alleles were
assigned by comparing the amplicon sequence to the plasmid
MLST database (http://pubmlst.org/plasmid/).
Plasmid sizes in the transconjugants were determined by
pulsed-ﬁeld gel electrophoresis using nuclease S1 (TaKaRa
Biotechnology, Dalian, China) digestion of plasmid DNA
prepared in agarose blocks (S1-PFGE). DNA fragments were
separated by PFGE on a CHEF-DR III apparatus (Bio-
Rad, Hercules, CA, USA) for 15 h at 6V/cm at 14◦C with
an initial pulse time of 1 s and a ﬁnal pulse time of
12 s. Southern hybridization was performed following S1-
PFGE using blaCTX-M, rmtB, and oqxB-speciﬁc digoxigen
in (DIG)-labeled probes. Hybridization was detected using
the DIG Nucleic Acid Detection Kit (Roche Diagnostics).
All plasmids were also analyzed by restriction fragment
length polymorphism (RFLP) as following: Plasmid DNA was
digested with EcoRI and electrophoresed in 1.0% agarose at
5V/cm for 2 h. DNA was visualized by EtBr staining. Cluster
analysis of digestion patterns generated dendrograms and
plasmid similarity was measured using BioNumerics software
(Applied Maths, Sint-Martens-Latem, Belgium) using the Dice
Similarity Index (DSI) (tolerance 1.5% and optimization 1.5%.
Plasmids with a DSI ≥80% were assigned to the same cluster
(designated with numbers 1, 2, 3, and 4). Letters were used
to discriminate RFLP patterns assigned to the same clusterthat
diﬀered by one or two restriction bands (i.e., 1a, 1b, 1c
etc.).
FIGURE 1 | RFLP patterns and characterization of multi-resistance 25 F2: A-: B- plasmids.
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Identification of Plasmid Addiction Systems
Plasmid-mediated addiction systems were identiﬁed using
primers and ampliﬁcation conditions were previously described
(Mnif et al., 2010). We screened for 8 major addiction
systems: ccdA-ccdB (involved in cell division), pemK-pemI (for
plasmid emergency maintenance), relB-relE (relaxed control
of stable RNA), parD-parE (DNA replication), vagC-vagD
(virulence-associated protein), hok-hok (host-killing), snrB-
snrC (RNA stability), and pndA-pndC (promotion of nucleic
acid).
Statistical Analysis
Statistical signiﬁcance for the comparison of prevalence data and
proportions was determined by the x2-test. p-values less than 0.05
were deemed to be statistically signiﬁcant.
Results
Antibiotic Resistance Phenotypes
A total of 103 transconjugants were examined in this study
and 96% exhibited multi-drug resistance phenotypes with to
ampicillin and streptomycin. More than half of the isolates
also showed resistance tocefotaxime, ceftriaxone, gentamicin,
kanamycin and ceftiofur (Table S1). The antimicrobial resistance
rates to other antibiotics tested as follows: amikacin (43.7%),
olaquindox (42.7%), tetracycline (40.8%), chloramphenicol
(34.0%), and ﬂorfenicol (26.2%). Most of these isolates were still
susceptible to levoﬂoxacin, enroﬂoxacin and ciproﬂoxacin.
Detection of Resistance Genes
Results of screening for resistance genes among 103
transconjugants are shown in Table S1. The predominant
resistance genes identiﬁed were blaCTX-M, rmtB, and oqxB
found in 82, 37, and 34 IncF-type plasmids, respectively.
Interestingly, there was a range of blaCTX-M genotypes including
M55 (n = 30), M14 (n = 20), M27 (n = 14), M65 (n = 13),
M15 (n = 3) and M24 and M3 (1 each). A smaller subset also
harbored qnrS, qepA, and qnrB genes (11, 6, and 3, respectively).
Sixty-one plasmids carried more than one resistance gene, and
the most prevalent combinations were blaCTX-M-rmtB (n = 28)
and blaCTX-M-oqxAB (n = 15). The qnrA, qnrC, and qnrD loci
were not found in any of the plasmids tested.
Characterization of IncF Plasmids
S1-PFGE and Southern blot hybridization analysis showed that
all the 103 multi-drug resistant strains contained plasmids
ranging in size from 60 to 194 kb (Table 1). This group contained
very diverse IncF-RST patterns. A total of 20 IncF-RSTs were
found that had replicon FII alone or in combination with FIA
or FIB. Various alleles were observed for each of FII (F2, F14,
F16, F18, F31, F33, F35, F36, F43, F46, and F58), FIA (A-, A1,
A3, and A4) and FIB (B-, B1, B8, B10, and B24) replicons.
Meanwhile, we found identical combinations were detected in a
number of diﬀerent plasmids; F2: A-: B- (n = 35) and F33: A-: B-
(n = 30) were the most common. Curiously, more than half of
F2: A-: B- positive E. coli strains (54.8%, 19/35) were recovered
from pigs, while F33: A-: B- (46.7%, 14/30) and F18: A-: B-
(50.0%, 5/10) were mainly found in E. coli strains recovered from
avians.
Further analysis of IncF plasmids bearing multi-resistance
genes was performed to see whether a particular resistance
gene was associated with a speciﬁc plasmid backbone deﬁned
by replicon type and addiction system content. Notably, there
was higher prevalence of resistance genes located on F2: A-
B- and F33: A-: B- plasmids than on the remaining replicon
types (Table 1). For instance, blaCTX-M-27, qepA, and qnrS were
preferentially associated with the F2: A-: B-. The blaCTX-M-55,
which was the most common identiﬁed β-lactamase in our study,
combined with F33: A-: B-; while rmtB and oqxB were mainly
found in F2: A-: B- and F33: A-: B-.
FIGURE 2 | RFLP patterns and characterization of multi-resistance 10 F18: A-: B1 plasmids.
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In order to assess relationships among the diﬀerent replicon
types of 103 IncF plasmids encoding variable resistance
determinants, RFLP analysis was conducted which allowed
visualization of variable clustering. However, our RFLP results
showed diverse plasmid proﬁles even among identical IncF-
RST groups. For instance, among 27/30 F33: A-: B- and 25/35
F2: A-: B- plasmids, 12 and 15 RFLP patterns were identiﬁed,
respectively. In addition, antimicrobial susceptibility, plasmid
size and antimicrobial resistance genes varied (Figures 1–3).
Addiction Systems
Of the eight addiction systems, the most frequently represented
systems were hok-sok (n = 86), followed by pemKI (n = 64),
snrBC (n = 59), ccdAB (n = 29), vagCD (n = 18), and
pndAC (n = 6). None of the IncF-type plasmids harbored parDE
and relBE. The average mean of addiction system was 2.54 with
a range of 0–5 per plasmid. Interestingly, when the replicon
FII was associated with FIA and FIB, the isolate also carried
more addiction systems than in the absence of this association
(Table 1). For instance, between the groups F2: A1: B1 and F2:
A-: B-, there was a mean of 4.5 vs. 1.9, and the combination of
F16: A-: B1 and F16: A-: B- with the mean of 3.0 vs. 1.7.
The number of diﬀerent types of addiction systems also varied
between the most prevalence replicon types in this study, F2: A-:
B- and F33: A-: B-. The number of snrBC loci on F33: A-: B- was
signiﬁcantly higher than on F2: A-: B- (P < 0.01). In contrast,
this number was reversed in the case of the ccdAB system
(Table 1).
Discussion
In the present study, the prevalence of the resistance
determinants blaCTX-M, PMQR genes and rmtB in IncF plasmids
from farm animals and pets in China was investigated and the
FIGURE 3 | RFLP patterns and characterization of multi-resistance 27 F33: A-: B- plasmids. The scale on the top left of the figure indicates the percentage of
similarity for the EcoRI restriction profiles of the IncF plasmids. aAntimicrobial for which the plasmids MICs fell within the resistant range; Antimicrobial abbreviations: A,
ampicillin; S, streptomycin; M, amikacin; K, kanamycin; G, gentamycin; R, ceftriaxone; C, cefotaxime; CT, ceftiofur; N, nalidixic acid; P, ciprofloxacin; E, enrofloxacin; L,
levoflox-acin; O, olaquindox; T, tetracycline; H, chloramphenicol and F, florfenicol. bPlasmids with a DSI ≥80% were assigned to the same cluster (designated with
numbers 1, 2, 3, 4 etc.). Letters were used to discriminate RFLP patterns assigned to the same cluster, but differing by one or two restriction bands (i.e., 1a, 1b, 1c
etc.). ND, not determined.
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characteristics of IncF plasmids were elucidated. One-hundred
and three IncF plasmids were recovered, the majority from
pigs and avians (85.4%, 88/103), and the remaining obtained
from pets (14.6%, 15/103), demonstrating that IncF plasmids
are prevalent among multi-drug resistant E. coli strains from
animals in China. The IncF plasmids identiﬁed in our study
were associated with multidrug resistance proﬁles that conferred
resistance to diﬀerent classes of antimicrobials simultaneously.
Most of IncF plasmids harbored blaCTX-M and, frequently
carried other resistance genes including qnr, qepA, oqxB, and
rmtB. These results are in agreement with previous ﬁndings
that the rmtB and PMQR genes are often linked with blaCTX-M-
located on the same plasmid (Dhanji et al., 2011; Li et al., 2012;
Matsumura et al., 2013; Chen et al., 2014). Together, these data
suggest that the spread of multiple ARGs on the same plasmid
has been an important dissemination mechanism of multidrug
resistance (Liebert et al., 1999).
The most impressive ﬁnding in this study was the diversity
of IncF plasmids. The result is similar to previous reports that
showed IncF plasmids are not a homogeneous group (Osborn
et al., 2000; Coque et al., 2008; Villa et al., 2010; Shin et al.,
2012). Moreover, heterogeneous RFLP patterns among identical
IncF-RST groups indicate that the cargos such as resistance genes
are also likely associated with the diversity of IncF plasmids.
Interestingly, we identiﬁed some particular resistance genes
were associated with the speciﬁc plasmid backbone deﬁned
by replicon type. For instance, blaCTX-M-3 was located on F2:
A-: B-, whereas it has been previously on detected IncL/M
plasmids (Golebiewski et al., 2007). As for blaCTX-M-14,which was
primarily found on F2: A-: B- in our study, but in Spain and
France, this gene was presented on the IncK plasmids (Diestra
et al., 2009; Valverde et al., 2009). Although the movements of
these resistance genes were attributed to transposable elements,
it is certain that the epidemic plasmids may accelerate their
widespread dissemination.
Interestingly, although RFLP patterns were diverse among
the plasmids, some with the same IncF-RST grouping did show
similar RFLP patterns with minor variations. These data agree
with previous studies reporting that IncF plasmids form a very
heterogeneous group (Dahmen et al., 2013b). Thus, the extensive
diversity of RFLP patterns among IncF plasmids from the
collection of E. coli used in this study may be due to frequent
recombination and acquisition resistance genes between the
plasmids (Partridge et al., 2011; Wiedenbeck and Cohan, 2011;
Cain and Hall, 2012).
In contrast to RFLP patterns, the content of addiction systems
seemed to diﬀer by replicon type. For instance, the snrBC
system was widely represented in F33: A-: B- but absent in
F2: A-: B-, while ccdAB was associated with F2: A-: B-. This
ﬁnding indicates a linkage between addiction systems and speciﬁc
plasmid backbones, but this must be investigated further. As
previously reported, plasmid addiction systems (PAS) contribute
to the stability and maintenance of plasmids and they have been
shown to facilitate plasmid dissemination even in the absence
of antibiotic selection (Hayes, 2003; Moritz and Hergenrother,
2007). Together, these data suggest a hypothesis that the diversity
of IncF plasmids can be driven by a combination of acquired
multiple resistance genes and addiction modules. In this way,
host maintenance would be facilitated by their spread in the E.
coli population.
In conclusion, we identiﬁed extensive diversity of RSTs,
plasmid sizes, addiction systems and RFLP patterns among
IncF plasmids, carrying blaCTX-M or PMQR or aminoglycoside
resistance genes. Considering the fact that the IncF plasmids have
been common reservoirs for diﬀusion of resistance genes, its wide
dissemination among Enterobacteriaceae especially among E. coli
could pose a serious threat to public health.
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